Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Radiation Research|April 1, 1990
Kidney and lung injury in irradiated rats protected from acute death by partial-body shieldingJ P Geraci, K L Jackson, M S Mariano, et al.
Haematologica|March 21, 1998
Bone marrow transplantation in a patient with chronic myeloid leukemia and achondroplasiaA Geromin, A Sperotto, R Fanin, et al.
Leukemia & Lymphoma|April 1, 1995
P170 glycoprotein expression and impaired anthracycline retention in chronic myeloid leukaemiaD Damiani, M Michieli, A Michelutti, et al.
Anti-Cancer Drugs|April 1, 1993
D-verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicinD Damiani, M Michieli, A Michelutti, et al.
Haematologica|May 1, 1996
Plasma cell P170 expression and response to treatment in multiple myelomaF Patriarca, C Melli, D Damiani, et al.
Haematologica|March 1, 1994
p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivativesM Michieli, D Damiani, A Michelutti, et al.
Leukemia & Lymphoma|February 1, 1993
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivativesM Michieli, A Michelutti, D Damiani, et al.
Leukemia & Lymphoma|November 8, 2001
Amifostine does not inhibit the toxic effects of anthracycline derivates or mitoxantrone on MDR tumor cell linesM Michieli, A Michelutti, D Damiani, et al.
British Journal of Haematology|May 3, 2000
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemiaM Michieli, D Damiani, A Ermacora, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2000
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemiaF Pea, D Russo, M Michieli, et al.
Pageof 5